Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism Mycobacterium tuberculosis inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H24N2O3 |
InChIKeyLGSYHXLETJBVDD-UHFFFAOYSA-N |
CAS Registry2097558-88-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tuberculosis | Preclinical | BR | 04 Dec 2024 |